期刊
FRONTIERS IN IMMUNOLOGY
卷 6, 期 -, 页码 1-6出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2015.00316
关键词
CD1d; innate immunity; inflammation; autoimmunity; cancer; sulfatide; lipids; neutrophils
类别
资金
- National Institutes of Health, USA [R01 CA100660, R01 AA020864]
- Juvenile Diabetes Research Foundation (JDRF) [24-2007-362]
Natural killer T cells (NKT) recognize self and microbial lipid antigens presented by non-polymorphic CD1d molecules. Two major NKT cell subsets, type I and II, express different types of antigen receptors (TCR) with distinct mode of CD1d/lipid recognition. Though type II NKT cells are less frequent in mice and difficult to study, they are predominant in human. One of the major subsets of type II NKT cells reactive to the self-glycolipid sulfatide is the best characterized and has been shown to induce a dominant immune regulatory mechanism that controls inflammation in autoimmunity and in anti-cancer immunity. Recently, type II NKT cells reactive to other self-glycolipids and phospholipids have been identified suggesting both promiscuous and specific TCR recognition in microbial immunity as well. Since the CD1d pathway is highly conserved, a detailed understanding of the biology and function of type II NKT cells as well as their interplay with type I NKT cells or other innate and adaptive T cells will have major implications for potential novel interventions in inflammatory and autoimmune diseases, microbial immunity, and cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据